Brief: OncoArendi Therapeutics To Cooperate With Polish Institute On Small Molecule Drugs

Molecure SA

16/06/2021 15:25

June 16 (Reuters) - OncoArendi Therapeutics SA  OAT.WA :
    * SIGNS DEAL WITH INTERNATIONAL INSTITUTE FOR MOLECULAR AND
CELLULAR BIOLOGY IN WARSAW
    * COOPERATION DEAL IS ON DISCOVERING AND DEVELOPING SMALL
MOLECULE
DRUGS FOR RNA FUNCTION MODULATION
    * SAYS UNDER DEAL COMPANY TO INVEST AT LEAST 2 MILLION
ZLOTYS ON
DEVELOPING SMR PLATFORM
    * SAYS STARTS EXCLUSIVE TALKS WITH INSTITUTE ON SIGNING
LICENCE
AGREEMENT FOR BIO-IT PLATFORM
    * SAYS MAIN MATTER OF LICENCE AGREEMENT WILL BE
RNA-FRAG-FINDER
AND RNA-DRUG-BINDER SOFTWARE, KEY ELEMENT OF PLATFORM
    * SAYS COOPERATION AND FUTURE USE OF LICENCED PRODUCT TO
INCLUDE
IDENTIFYING AND MODELLING  IMPACT OF SMALL ORGANIC CHEM
PARTICLES ON RNA FOR DRUG DEVELOPMENT

Source text for Eikon:  ID:nEM7Yp0vWa 
Further company coverage:  OAT.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))